IBD Treatment Market Trends

Growth Drivers

• Rising awareness and advancements in early diagnosis: As investments and involvements in tech-based medical commodities increase, the pace of adoption in the inflammatory bowel disease treatment market accelerates. The penetration of advanced technologies such as AI and automatic monitoring systems is revolutionizing patient outcomes in therapeutic applications. On this note, in February 2025, Crohn's & Colitis Foundation allocated a supportive fund to Mobius Care to create an AI-powered pathology tool for predicting and identifying the response to using IBD therapies. In addition, spreading knowledge about the benefits of early detection in acquiring long-acting and faster effects from medicines is inflating demand in this category.

• Introduction of biologics and targeted therapies: The development of novel drugs is anticipated to boost growth in the market. Several clinical studies have demonstrated the efficacy of new biological medicines, such as monoclonal antibodies and inhibitors, which are helping companies attain maximum regulatory approvals. For instance, in February 2025, Sanofi, in collaboration with Teva Pharmaceuticals, released promising results from the RELIEVE UCCD phase IIb trial on duvakitug for using it in treating moderate-to-severe ulcerative colitis (UC) and Crohn’s disease (CD). This human IgG1-λ2 monoclonal antibody showcased 36% & 48% and 26% & 48% response rates for 450 mg & 900 mg doses in UC and CD, respectively.

Challenges

• Economic disparities in various regions: Being associated with the chronic disease family, treatment for IBD becomes expensive for the majority population from underserved areas. The treatment includes surgery, medicines, bowel rest, and others for a prolonged time since no single treatment is completely able to cure patients. Thus, the whole procedure may be financially exhausting for residents, particularly in low- and middle-income countries. As a result, this barrier restricts wide adoption and global expansion in the market.